• <dfn id="q240u"></dfn>
    • PTEN

      PTEN產(chǎn)品

      • 所有產(chǎn)品(8)
      • PTEN抑制劑 (3)
      • PTEN抗體 (3)
      • PTEN激活劑 (2)
      目錄號 產(chǎn)品名 產(chǎn)品描述 文獻(xiàn)引用 實(shí)驗(yàn)數(shù)據(jù)
      S7310 SF1670 SF1670是一種高度有效且專一的PTEN的抑制劑,其IC50 為 2 μM。
      Oncol Rep, 2025, 54(4)125
      Nat Biomed Eng, 2024, 10.1038/s41551-024-01273-9
      J Biol Chem, 2024, S0021-9258(24)01808-8
      S8651 bpV (HOpic) bpV (HOpic) (Bisperoxovanadium (HOpic))是一種有效的PTEN抑制劑,IC50為14 nM。它對PTP-β和PTP-1B的IC50值分別約是對PTEN的IC50的350倍和1800倍。
      Brain Behav Immun, 2025, 130:106111
      Cell Death Dis, 2025, 16(1):226
      Stem Cell Res Ther, 2025, 16(1):455
      S8174 VO-Ohpic trihydrate VO-Ohpic是一種有效的PTEN (phosphatase and tensin homolog)抑制劑,IC50為35 nM。
      Cell Commun Signal, 2025, 23(1):431
      Nature, 2024, 631(8019):170-178
      Aging (Albany NY), 2023, 15(6):2275-2292
      S9190 Oroxin B Oroxin B (Hypocretin-2), one of flavonoids isolated from traditional Chinese herbal medicine Oroxylum indicum (L.) Vent, selectively induces tumor-suppressive ER stress in malignant lymphoma cells and has antioxidant activity. Oroxin B significantly inhibits proliferation and induce apoptosis, which may be strongly associated with the inhibiting COX-2/VEGF and PTEN/PI3K/AKT signaling pathway in SMMC-7721 cells, Oroxin B potentially be used as a novel therapeutic agent for liver cancer.COX-2, VEGF, PI3K, and p-AKT expression levels are downregulated, while PTEN is upregulated after Oroxin B treatment.
      Environ Pollut, 2023, 323:121306
      Theranostics, 2022, 12(2):910-928
      J Cancer, 2021, 12(7):2140-2150
      F0499 Phospho-PTEN (Ser380/Thr382/383) Antibody [K19C17] Phospho-PTEN (Ser380),Phospho-PTEN (Ser380/Thr382/383),PTEN (phospho S380)
      F2618 Phospho-PTEN (Thr366) Antibody [A11K14]
      S0918 Ginkgolic acid C17:1 Ginkgolic acid C17:1 (GAC 17:1) 通過廢除上游的 JAK2Src 來抑制 STAT3 的組成性激活。Ginkgolic acid C17:1 可以誘導(dǎo) PTEN 和 SHP-1 的大量表達(dá)。Ginkgolic acid C17:1 誘導(dǎo)腫瘤細(xì)胞凋亡。
      F3548New PTEN Antibody [J22G2]
      S7310 SF1670 SF1670是一種高度有效且專一的PTEN的抑制劑,其IC50 為 2 μM。
      Oncol Rep, 2025, 54(4)125
      Nat Biomed Eng, 2024, 10.1038/s41551-024-01273-9
      J Biol Chem, 2024, S0021-9258(24)01808-8
      S8651 bpV (HOpic) bpV (HOpic) (Bisperoxovanadium (HOpic))是一種有效的PTEN抑制劑,IC50為14 nM。它對PTP-β和PTP-1B的IC50值分別約是對PTEN的IC50的350倍和1800倍。
      Brain Behav Immun, 2025, 130:106111
      Cell Death Dis, 2025, 16(1):226
      Stem Cell Res Ther, 2025, 16(1):455
      S8174 VO-Ohpic trihydrate VO-Ohpic是一種有效的PTEN (phosphatase and tensin homolog)抑制劑,IC50為35 nM。
      Cell Commun Signal, 2025, 23(1):431
      Nature, 2024, 631(8019):170-178
      Aging (Albany NY), 2023, 15(6):2275-2292
      F0499 Phospho-PTEN (Ser380/Thr382/383) Antibody [K19C17] Phospho-PTEN (Ser380),Phospho-PTEN (Ser380/Thr382/383),PTEN (phospho S380)
      F2618 Phospho-PTEN (Thr366) Antibody [A11K14]
      F3548New PTEN Antibody [J22G2]
      S9190 Oroxin B Oroxin B (Hypocretin-2), one of flavonoids isolated from traditional Chinese herbal medicine Oroxylum indicum (L.) Vent, selectively induces tumor-suppressive ER stress in malignant lymphoma cells and has antioxidant activity. Oroxin B significantly inhibits proliferation and induce apoptosis, which may be strongly associated with the inhibiting COX-2/VEGF and PTEN/PI3K/AKT signaling pathway in SMMC-7721 cells, Oroxin B potentially be used as a novel therapeutic agent for liver cancer.COX-2, VEGF, PI3K, and p-AKT expression levels are downregulated, while PTEN is upregulated after Oroxin B treatment.
      Environ Pollut, 2023, 323:121306
      Theranostics, 2022, 12(2):910-928
      J Cancer, 2021, 12(7):2140-2150
      S0918 Ginkgolic acid C17:1 Ginkgolic acid C17:1 (GAC 17:1) 通過廢除上游的 JAK2Src 來抑制 STAT3 的組成性激活。Ginkgolic acid C17:1 可以誘導(dǎo) PTEN 和 SHP-1 的大量表達(dá)。Ginkgolic acid C17:1 誘導(dǎo)腫瘤細(xì)胞凋亡。
      F3548New PTEN Antibody [J22G2]
      在線咨詢
      聯(lián)系我們
        • <dfn id="q240u"></dfn>
        • 男同教练gay互吃鳮 | 欧美成在线视频 | 91精品久久久久无码人妻 | 末成年女A片一区二区 | 久久不卡网 |